Keiko Yamamoto

3PUBLICATIONS
21CO-AUTHORS
Molecular targetsMedical ethics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 08, 2026
Tumor-Specific Success Probabilities and Factors Associated With Phase III Trials in Oncology Drug Development.

|Aug 04, 2025
Retrospective Analysis of Master Protocols in Tumor-Agnostic Drug Development: Evaluation of Application to Single-Agent Therapies With ORR as the Endpoint for Approval of Oncology Drugs.

Keiko Yamamoto, Kentaro Takeda, Hideki Maeda

|Feb 01, 2024
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer.

Kan Yonemori, Keiichi Fujiwara, Kosei Hasegawa

Pageof 1

Frequent Collaborators

2 joint publications

Hideki Maeda

1 joint publications

Kan Yonemori

1 joint publications

Keiichi Fujiwara

1 joint publications

Kosei Hasegawa